testosterone undecanoate Aveed
Selected indexed studies
- Testosterone Undecanoate-Schering AG. (Drugs R D, 2004) [PMID:15563244]
- Male contraception. (Best Pract Res Clin Obstet Gynaecol, 2014) [PMID:24947599]
- Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. (Andrology, 2025) [PMID:39252657]
_Worker-drafted node — pending editorial review._
Connections
testosterone undecanoate Aveed is a side effect of
Sources
- Testosterone Undecanoate-Schering AG. (2004) pubmed
- Testosterone undecanoate in the treatment of male hypogonadism. (2010) pubmed
- Testosterone undecanoate administration prevents declines in fat-free mass but not physical performance during simulated multi-stressor military operations. (2022) pubmed
- Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. (2025) pubmed
- Long-term testosterone undecanoate treatment in the elderly testosterone deficient male: An observational cohort study. (2022) pubmed
- Male contraception. (2014) pubmed
- Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States. (2017) pubmed
- Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism. (2025) pubmed
- Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats. (2022) pubmed
- A long-acting depot formulation of testosterone (Aveed). (2014) pubmed